𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Structure-guided design of peptidic ligand for human prostate specific antigen

✍ Scribed by MD Imtaiyaz Hassan; Vijay Kumar; Rishi K. Somvanshi; Sharmistha Dey; Tej P. Singh; Savita Yadav


Book ID
105360728
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
404 KB
Volume
13
Category
Article
ISSN
1075-2617

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Prostate specific antigen (PSA) is a member of kallikrein family having serine protease‐like activity and acts as a prognostic marker of prostate carcinoma. Various studies have been performed on inhibition of PSA and such targeting requires the identification of highly selective peptide inhibitors. PSA was purified from human seminal plasma by rapid and efficient methods, and binding studies for various peptides were carried out by fluorescence spectroscopy and SPR. The β€˜S’ of PSA is predominated by hydrophobic residues, and hence many hydrophobic peptides were used to determine their binding affinity to PSA by fluorescence spectroscopy. We observed that LLFW, FFKW, and KFW binds strongly to PSA, among them LLFW showed strong binding. SPR also showed strong binding affinity of PSA toward peptides with hydrophobic and basic residues. Among the peptides used, FWYS showed dramatic increase in binding affinity (10^βˆ’10^ M). The peptides analyzed for binding studies, suggests that peptide with Trp residue along with basic or hydrophobic amino acids may be useful for designing specific inhibitors for PSA. The strong affinities of designed peptides for PSA can be a valuable tool for designing therapeutic agents for prostate carcinomas. Copyright Β© 2007 European Peptide Society and John Wiley & Sons, Ltd.


πŸ“œ SIMILAR VOLUMES


Induction of human cytotoxic T lymphocyt
✍ Xue, Bao-Hua; Zhang, Yong; Sosman, Jeffrey A.; Peace, David J. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 2 views

Prostate-specific antigen (PSA), a tissue-specific protein expressed by most adenocarcinomas of the prostate, might be a useful target for T-cell-mediated immunotherapy of prostate cancers. The current study examined whether it is possible to elicit human cytotoxic T lymphocytes (CTL) with specifici